StemCyte-KY announced on May 14, 2026, that it has obtained an internal control project review report issued by a certified public accountant, in compliance with regulatory requirements. The report covers the period from January 1, 2025, to December 31, 2025. The CPA provided an unqualified opinion (unmodified conclusion), indicating that the company's internal control systems are operating effectively. The full report is available on the Market Observation Post System.

FACT BOX

  • Source: PR Times
  • Category: 其他